1.0800
-0.1300
(-10.74%)
At close: January 10 at 4:00:01 PM EST
1.0800
0.00
(0.00%)
After hours: 7:49:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-16,876.8740
-21,047.6180
-13,549.2340
-8,799.4870
-1,034.6200
Investing Cash Flow
-14,757.3160
--
-536.8360
-250.0000
--
Financing Cash Flow
94,758.7470
--
-102.0710
58,394.0360
1,149.0540
End Cash Position
84,801.5560
14,449.8270
35,497.4450
49,685.5860
341.0370
Capital Expenditure
--
--
-536.8360
-250.0000
--
Issuance of Capital Stock
--
--
--
58,394.0360
1,000.0000
Issuance of Debt
--
--
--
--
149.0540
Free Cash Flow
-31,634.1900
-21,047.6180
-14,086.0700
-9,049.4870
-1,034.6200
12/31/2020 - 10/20/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENSC Ensysce Biosciences, Inc.
7.49
-5.31%
PXMD PaxMedica, Inc.
0.0580
-10.77%
NBY NovaBay Pharmaceuticals, Inc.
0.6970
+9.16%
NLSP NLS Pharmaceutics AG
2.3200
-3.73%
CMPX Compass Therapeutics, Inc.
1.7700
-4.84%
SNSE Sensei Biotherapeutics, Inc.
0.5125
-3.30%
ALLR Allarity Therapeutics, Inc.
1.0400
-2.80%
TCBP TC Biopharm (Holdings) Plc
0.4005
-1.11%
BDRX Biodexa Pharmaceuticals Plc
4.5200
+3.91%
DBVT DBV Technologies S.A.
4.9700
+29.77%